Literature DB >> 17313026

[A case of Erdheim-Chester disease effectively treated by cyclophosphamide and prednisolone].

Shuichi Yano1, Kanako Kobayashi, Kazuhiro Kato, Yoshiyuki Tokuda, Toshikazu Ikeda, Hiroyuki Takeyama.   

Abstract

Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis with a characteristic long bone lesion. Although about half of the patients have extraosseous organs, pulmonary involvement is very rare. We report a 55-year-old man with ECD who complained of severe dyspnea despite home oxygen therapy with noninvasive positive pressure ventilation. Continuous PGI2 administration was not very effective, but administration of cyclophosphamide and prednisolone induced rapid improvement of respiratory failure and the effect for six months on arterial blood gas analysis and stability of the disease state persisted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17313026

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  2 in total

1.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

2.  [Erdheim-Chester disease of the orbit with compressive optic neuropathy].

Authors:  K Manousaridis; J Casper; M P Schittkowski; H Nizze; R F Guthoff
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.